| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Research and Development | EVP, Research & Development | Cso/ EVP Disc & Trans Research
1 company
Dana Aftab is EVP, Research and Development at EXEL. From January 2023 to May 2026, the filings on record show 0 open-market purchases and 12 sales. Dana Aftab's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $43.0M at current prices.
Historically, Dana Aftab's trades have earned a below-average insider score of 41/100 across 13 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -24.5%.
The EXEL filings lean toward selling, a net 499,251 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2023 | EXEL Exelixis, Inc. | Cso/ EVP Disc & Trans Research | Sell10b5-1 | 4,600 | $22.47 | $103,362.00 | -1.1% | -6.4% | +15.6% | |
| Feb 28, 2023 | EXEL Exelixis, Inc. | Cso/ EVP Disc & Trans Research | Sale+OE | 82,500 | $17.50 | $1,443,750.00 | -19.0% | +11.3% | +28.3% |